Photo: Natalia Lebedinskaia/Getty Images
AirStrip Technologies announced it has entered into a committed $50 million credit facility with OrbiMed.
In addition, OrbiMed made a preferred stock investment in AirStrip.
WHAT IT DOES
AirStrip provides clinical surveillance applications and alarm communication management technology to hospitals, accessible via native mobile applications and the web.
It also provides clinical decision support and predictive analytics tools, including the apnea-hypopnea index, which measures the severity of obstructive sleep apnea, and telemetry optimization that transforms data into foresight to help healthcare professionals develop a care plan.
AirStrip cardiology allows healthcare professionals to view, edit and confirm 12-lead ECGs from mobile devices and the web, while AirStrip obstetrics monitors the progress of labor and delivery in near real time.
The AirStrip alarm management feature is a vendor-agnostic offering designed to help hospitals manage alarms. An alarm dashboard allows monitor technicians to triage and dispatch alarms to clinicians on the floor, and hospital leadership can track every alarm and escalation with audit trails.
"This funding will accelerate our transformation of how clinicians access and act on critical clinical information," Dr. Haris Naseem, CEO of AirStrip, said in a statement.
"We’re unifying fragmented data and delivering timely, actionable insights to facilitate improved decision-making and enhanced patient safety at every stage of care."
MARKET SNAPSHOT
AirStrip acquired two companies this year alone.
In June, the company acquired Fifth Eye, developer of an FDA-cleared AHI System.
"This acquisition accelerates a fundamental shift in how clinical intelligence is delivered. We are breaking down silos and equipping care teams with near real-time, predictive insights that can transform patient safety across the continuum of care," Naseem said in a statement.
In January, the company acquired DecisionHealth, a provider of clinical decision support and visualization tools.
DecisionHealth's platform provides clinicians with actionable insights via advanced data aggregation, patient surveillance and digital protocol management. By integrating DecisionHealth’s technology into AirStrip’s existing platform, healthcare organizations can enhance their ability to monitor patients, make data-driven decisions and respond to critical clinical scenarios.
In 2023, GE HealthCare and AirStrip announced a joint commercialization agreement. GE HealthCare became the exclusive distributor of AirStrip cardiology and patient monitoring offerings in the U.S., providing data visualization technology that healthcare systems can purchase together.
According to the two companies, the acquisition brought together GE HealthCare's ECG, cardiac output and patient monitoring products with AirStrip's data visualization and monitoring capabilities available to clinical care teams on mobile devices and the web.
Pairing GE HealthCare's technology and AirStrip also allows clinicians to view patient data from a distance and view multiple patients on one screen by level of priority.
